A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule.
Saved in:
| Title: | A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule. |
|---|---|
| Authors: | Hosseini, Iraj1 (AUTHOR) hosseini.iraj@gene.com, Fleisher, Brett1 (AUTHOR), Getz, Jennifer1 (AUTHOR) fleisheb@gene.com, Decalf, Jérémie1 (AUTHOR), Kwong, Mandy1 (AUTHOR), Ovacik, Meric1 (AUTHOR), Bainbridge, Travis W.1 (AUTHOR), Moussion, Christine1 (AUTHOR), Rao, Gautham K.1 (AUTHOR), Gadkar, Kapil1 (AUTHOR), Kamath, Amrita V.1 (AUTHOR), Ramanujan, Saroja1 (AUTHOR) |
| Source: | Pharmaceutics. May2024, Vol. 16 Issue 5, p660. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics16050660 |
